Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Completed 6Active not recruiting 2

Sponsor Class

INDUSTRY 5OTHER 2NETWORK 1

Study Type

Interventional 5Observational 3

Sponsor

Cancer Type

Genitourinary 84Breast 8Lymphoid 3Plasma cell 2Other hematologic neoplasm 2Myeloid 2Tumor-Agnostic 1Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 7Premenopausal Breast Cancer 1Hereditary Sensory and Autonomic Neuropathies 1Breast Neoplasms, Male 1

Interventions

Trastuzumab 260Paclitaxel 216Cyclophosphamide 173Docetaxel 146Letrozole 126Fulvestrant 121Capecitabine 121Doxorubicin 111Carboplatin 98Bevacizumab 90exemestane 88Anastrozole 85Tamoxifen 77Lapatinib 77pembrolizumab 68Albumin-Bound Paclitaxel 67pertuzumab 62palbociclib 60Taxes 59Gemcitabine 57eribulin 48130-nm albumin-bound paclitaxel 47Radiotherapy 46Everolimus 44Ado-Trastuzumab Emtansine 43Vinorelbine 39ixabepilone 32Epirubicin 30Cisplatin 30pegfilgrastim 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Has results × Leuprolide × Breast × Clear all
NCT04293393 2026-03-12

CARABELA

Spanish Breast Cancer Research Group

Phase 2 Active not recruiting
200 enrolled 27 charts
Breast

Breast Neoplasms

NCT01674140 2026-02-10

e3

SWOG Cancer Research Network

Phase 3 Active not recruiting
1,939 enrolled 15 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT03056755 2026-01-13

BYLieve

Novartis

Phase 2 Completed
383 enrolled 16 charts
Breast

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT02941926 2023-10-24

COMPLEEMENT-1

Novartis

Phase 3 Completed
3,246 enrolled 11 charts
Breast

Breast Neoplasms

NCT03209518 2019-11-01

Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer"

Takeda

Completed
312 enrolled 17 charts
Breast

Premenopausal Breast Cancer

NCT02134977 2016-10-18

Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients"

Takeda

Completed
2,816 enrolled 29 charts
Breast

Breast Neoplasms

NCT00903162 2016-04-18

Extended Endocrine Therapy for Premenopausal Women With Breast Cancer

Dana-Farber Cancer Institute

Phase 2 Completed
17 enrolled 5 charts
Breast

Breast Neoplasms

NCT02154139 2016-02-17

Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)"

Takeda

Completed
651 enrolled 12 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡